OpenVSafe by OpenVAERS
Search V-safe

AL5-21888-36014

2 vaccinations 16 coded responses 24 check-ins 16 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
220 / VA
Registered
2021-03-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1768445 (opens in a new window) high 8 / 11 -3 0 of 5 VAERS symptoms same dose (2) VA matches 2021-04-06 / 2021-04-06 / 2021-10-07
received 183 days after the last call
case 469495

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-16
    Registered in v-safe
  2. 2021-03-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood corticotrophin decreased, Cortisol decreased, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Adrenal insufficiency, Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-23
    Survey response — day 7, dose 1
    MedDRA: Adrenocorticotropic hormone deficiency, Cushing's syndrome, Glucocorticoid deficiency, Pituitary gland operation, Pituitary-dependent Cushing's syndrome, Pre-existing disease, Secondary adrenocortical insufficiency — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 25 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-06
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-06
    Survey response — day 0, dose 2
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adrenal insufficiency, Adrenocorticotropic hormone deficiency, Glucocorticoid deficiency, Pituitary gland operation, Pituitary-dependent Cushing's syndrome, Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-07
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-04-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Currently 27 weeks post op for pituitary Cushing's disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Medical counselling, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol. · Healthcare visit (other): Messaged by endocrinologist through her portal.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-12
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-04-13
    Survey response — day 7, dose 2
    MedDRA: Adrenocorticotropic hormone deficiency, Cortisol decreased, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Currently 28 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-22
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-04-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-04
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-05-11
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-05-18
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  28. 2021-07-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-10-05
    Survey response — 6 months, dose 2
    MedDRA: Hypothyroidism — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Hypothyroidism
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-05
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2021-10-07
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Pfizer-BioNTech
22021-04-06Pfizer-BioNTech

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-17

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-03-18

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

Release 6 — days 1–6 daily, dose 1

2021-03-19

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-03-20

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-03-21

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-03-22

Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

Release 6 — day 7, dose 1

2021-03-23

Systemic reaction (other): Currently 25 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

Release 7 — day 0, dose 2

2021-04-06

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

Release 7 — days 1–6 daily, dose 2

2021-04-07

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-04-08

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushing's disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-04-09

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-04-10

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-04-11

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

2021-04-12

Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Healthcare visit (other): Messaged by endocrinologist through her portal.

Release 7 — day 7, dose 2

2021-04-13

Systemic reaction (other): Currently 28 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.

Release 10 — 6 months, dose 2

2021-10-05

Symptoms: Hypothyroidism

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SDHypothyroidism · · ✓
SROAdrenal insufficiency ✓ ✓ ✓
SROAdrenocorticotropic hormone deficiency ✓ ✓ ✓
SROBlood corticotrophin decreased ✓ ✓ ✓
SROCortisol decreased ✓ ✓ ✓
SROCushing's syndrome ○ ✓ ○
SROGlucocorticoid deficiency ✓ ✓ ✓
SROPituitary gland operation ✓ ✓ ✓
SROPituitary-dependent Cushing's syndrome ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROSecondary adrenocortical insufficiency ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release